Epigenetic alterations in acute myeloid leukemias.

Epigenetic alterations in acute myeloid leukemias.

Item
http://www.wikidata.org/entity/Q38264968
Epigenetic treatment of solid tumours: a review of clinical trialsDifferential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AMLDe novo dominant ASXL3 mutations alter H2A deubiquitination and transcription in Bainbridge-Ropers syndrome.The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients.Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid.Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.Touch, act and go: landing and operating on nucleosomes.A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.STAT3 signaling pathway is involved in decitabine induced biological phenotype regulation of acute myeloid leukemia cellsSpecial Issue: Epigenetics
P2860

Epigenetic alterations in acute myeloid leukemias.

Item
http://www.wikidata.org/entity/Q38264968
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Epigenetic alterations in acute myeloid leukemias.
@en
type
label
Epigenetic alterations in acute myeloid leukemias.
@en
prefLabel
Epigenetic alterations in acute myeloid leukemias.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Epigenetic alterations in acute myeloid leukemias.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698